D

DURECT Corp
D

DRRX

1.90500
USD
0.01
(0.53%)
مغلق
حجم التداول
21,506
الربح لكل سهم
-0
العائد الربحي
-
P/E
-4
حجم السوق
59,136,117
أصول ذات صلة
A
ALDX
0.07500
(1.41%)
5.38000 USD
A
AQST
-0.00500
(-0.12%)
4.11000 USD
A
AXSM
0.460
(0.42%)
109.210 USD
B
BHC
0.82500
(10.97%)
8.34500 USD
B
BNTC
0.290
(2.28%)
13.020 USD
CAH
CAH
-0.570
(-0.38%)
149.660 USD
المزيد
الأخبار المقالات

العنوان: DURECT Corp

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories, which include new chemical entitiesand proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from Europe.